FASN and tuberculosis: Many of them have also been applied in the development of anti-tuberculosis drugs, such as drugs targeting MurB and MurE enzymes [92], flavoenzyme DprE1 [93], dTDP-4-dehydrorhamnose reductase (RmlD) [94], LipU protein [95], and enoyl-acyl carrier protein reductase [96].